Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1998 1
2004 1
2006 2
2007 1
2008 2
2009 2
2010 5
2011 3
2012 3
2013 6
2014 7
2015 8
2016 5
2017 5
2019 1
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Results by year
Filters applied: . Clear all
Page 1
Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?
Rana U, Driedger M, Sereda P, Pan S, Ding E, Wong A, Walmsley S, Klein M, Kelly D, Loutfy M, Thomas R, Sanche S, Kroch A, Machouf N, Roy-Gagnon MH, Hogg R, Cooper CL; Canadian Observational Cohort (CANOC) Collaboration. Rana U, et al. Among authors: machouf n. BMC Infect Dis. 2019 Nov 21;19(1):982. doi: 10.1186/s12879-019-4617-8. BMC Infect Dis. 2019. PMID: 31752729 Free PMC article.
Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIV.
Sangaré MN, Baril JG, de Pokomandy A, Laprise C, Deshaies C, Klein M, Thomas R, Tremblay C, Roger M, Pexos C, Greenwald Z, Machouf N, Durand M, Hardy I, Dakouo M, Laporte L, Trottier H. Sangaré MN, et al. Among authors: machouf n. Medicine (Baltimore). 2020 Nov 20;99(47):e23335. doi: 10.1097/MD.0000000000023335. Medicine (Baltimore). 2020. PMID: 33217873 Free PMC article.
Treatment Switch to Dolutegravir With 2 Nucleoside Reverse-Transcriptase Inhibitors (NRTI) in Comparison to Continuation With Protease Inhibitor/Ritonavir Among Patients With Human Immunodeficiency Virus at Risk for Prior NRTI Resistance: A Cohort Analysis of Real-World Data.
Sangaré MN, Baril JG, de Pokomandy A, Ferreira Guerra S, Carabali M, Laprise C, Thomas R, Klein M, Tremblay C, Roger M, Pexos C, Greenwald ZR, Machouf N, Durand M, Hardy I, Dakouo M, Trevisan A, Laporte L, Schnitzer ME, Trottier H. Sangaré MN, et al. Among authors: machouf n. Open Forum Infect Dis. 2020 Sep 4;7(11):ofaa404. doi: 10.1093/ofid/ofaa404. eCollection 2020 Nov. Open Forum Infect Dis. 2020. PMID: 33204746 Free PMC article.
Cohort profile: the Canadian Observational Cohort collaboration.
Palmer AK, Klein MB, Raboud J, Cooper C, Hosein S, Loutfy M, Machouf N, Montaner J, Rourke SB, Smieja M, Tsoukas C, Yip B, Milan D, Hogg RS; CANOC Collaboration. Palmer AK, et al. Among authors: machouf n. Int J Epidemiol. 2011 Feb;40(1):25-32. doi: 10.1093/ije/dyp393. Epub 2010 Feb 15. Int J Epidemiol. 2011. PMID: 20157000 No abstract available.
Tolerability is more important than simplicity for treatment durability.
Trottier B, Machouf N, Huchet E, Lavoie S, Vezina S, Boissonnault M, Charest L, Munoz M, Legault D, Longpré D, Thomas R. Trottier B, et al. Among authors: machouf n. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19765. doi: 10.7448/IAS.17.4.19765. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397509 Free PMC article.
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients.
Antoniou T, Szadkowski L, Walmsley S, Cooper C, Burchell AN, Bayoumi AM, Montaner JS, Loutfy M, Klein MB, Machouf N, Tsoukas C, Wong A, Hogg RS, Raboud J; Canadian Observational Cohort (CANOC) collaboration. Antoniou T, et al. Among authors: machouf n. BMC Infect Dis. 2017 Apr 11;17(1):266. doi: 10.1186/s12879-017-2379-8. BMC Infect Dis. 2017. PMID: 28399819 Free PMC article.
Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada.
Patterson S, Cescon A, Samji H, Chan K, Zhang W, Raboud J, Burchell AN, Cooper C, Klein MB, Rourke SB, Loutfy MR, Machouf N, Montaner JS, Tsoukas C, Hogg RS; CANOC collaboration. Patterson S, et al. Among authors: machouf n. BMC Infect Dis. 2015 Jul 17;15:274. doi: 10.1186/s12879-015-0969-x. BMC Infect Dis. 2015. PMID: 26183704 Free PMC article.
Increased mortality among Indigenous persons in a multisite cohort of people living with HIV in Canada.
Benoit AC, Younger J, Beaver K, Jackson R, Loutfy M, Masching R, Nobis T, Nowgesic E, O'Brien-Teengs D, Whitebird W, Zoccole A, Hull M, Jaworsky D, Benson E, Rachlis A, Rourke SB, Burchell AN, Cooper C, Hogg RS, Klein MB, Machouf N, Montaner JSG, Tsoukas C, Raboud J. Benoit AC, et al. Among authors: machouf n. Can J Public Health. 2017 Jun 16;108(2):e169-e175. doi: 10.17269/cjph.108.5708. Can J Public Health. 2017. PMID: 28621653 Free PMC article.
Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in Canada.
Samji H, Taha TE, Moore D, Burchell AN, Cescon A, Cooper C, Raboud JM, Klein MB, Loutfy MR, Machouf N, Tsoukas CM, Montaner JS, Hogg RS; Canadian Observational Cohort (CANOC) Collaboration. Samji H, et al. Among authors: machouf n. HIV Med. 2015 Feb;16(2):76-87. doi: 10.1111/hiv.12173. Epub 2014 Sep 1. HIV Med. 2015. PMID: 25174373 Free PMC article.
46 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page